Cargando…
Design, synthesis, and biological study of 4-[(2-nitroimidazole-1H-alkyloxyl)aniline]-quinazolines as EGFR inhibitors exerting cytotoxicities both under normoxia and hypoxia
PURPOSE: In order to get novel EGFR inhibitors exerting more potency in tumor hypoxia than in normoxia. METHODS: A series of 4-[(2-nitroimidazole-1H-alkyloxyl)aniline]-quinazolines were designed and synthesized, and their in vitro cytotoxicity and EGFR inhibitory activity were evaluated. Molecule do...
Autores principales: | Cheng, Weiyan, Wang, Suhua, Yang, Zhiheng, Tian, Xin, Hu, Yongzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717862/ https://www.ncbi.nlm.nih.gov/pubmed/31695326 http://dx.doi.org/10.2147/DDDT.S209481 |
Ejemplares similares
-
Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
por: Wei, Huiqiang, et al.
Publicado: (2016) -
4-[(7-Fluoroquinazolin-4-yl)oxy]aniline
por: Jia, Jing, et al.
Publicado: (2010) -
Proteobacteria and Firmicutes Secreted Factors Exert Distinct Effects on Pseudomonas aeruginosa Infection under Normoxia or Mild Hypoxia
por: Charalambous, Anna, et al.
Publicado: (2022) -
Substrate oxidation and the influence of breakfast in normobaric hypoxia and normoxia
por: Griffiths, Alex, et al.
Publicado: (2019) -
Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven?
por: Heyman, Samuel N., et al.
Publicado: (2023)